Results 111 to 120 of about 2,195 (166)

Endometriotic Tissue-derived Exosomes Downregulate NKG2D-mediated Cytotoxicity and Promote Apoptosis: Mechanisms for Survival of Ectopic Endometrial Tissue in Endometriosis. [PDF]

J Immunol
Björk E, Israelsson P, Nagaev I, Nagaeva O, Lundin E, Ottander U, Mincheva-Nilsson L.   +6 more
europepmc   +1 more source

Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancer. [PDF]

J Biol Eng
Lee SG, Lee M, Lee HM, Son GH, Yoon SR, Chae BH, Kim DS, Lee KM, Kim YS.   +8 more
europepmc   +1 more source

Exploring the correlation and mechanism of natural killer cell cytotoxic sensitivity against gastric cancer. [PDF]

Oncol Res
Yang W, Chen H, Zhang Z, Xia Z, Jin Y, Yang Z.   +5 more
europepmc   +1 more source

γδT cells, a key subset of T cell for cancer immunotherapy. [PDF]

Front Immunol
Lv J, Liu Z, Ren X, Song S, Zhang Y, Wang Y.   +5 more
europepmc   +1 more source

CAR-NK cell therapy in multiple myeloma: from preclinical and clinical landscape to joining the force for treatment strategies optimization. [PDF]

Cell Commun Signal
Yazdanparast S, Bakhtiyaridovvombaygi M, Davoodi-Moghaddam Z, Asadi G, Monjezi F, Kiyamehr P, Gharehbaghian A, Abroun S, Moradi N.   +8 more
europepmc   +1 more source

Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia. [PDF]

Leukemia
Li YR, Shen X, Chen Y, Zhu Y, Huang J, Oliai C, Yang L.   +6 more
europepmc   +1 more source

Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells. [PDF]

Acta Neuropathol Commun
Meehan B, Adnani L, Zhu X, Tawil N, Garnier D, Nakano I, Huang S, Rak J.   +7 more
europepmc   +1 more source

MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses. [PDF]

Cancer Cell Int
Charoghdoozi K, Balighi MJ, Amiri AM, Dehnavi S, Sadeghi M.   +4 more
europepmc   +1 more source

Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder. [PDF]

Exp Hematol Oncol
Mai Q, He B, Deng S, Zeng Q, Xu Y, Wang C, Pang Y, Zhang S, Li J, Zeng J, Huang L, Fu Y, Li C, Li T, Xu X, Zhang L.   +15 more
europepmc   +1 more source

IL-15-induced CD38⁺HLA-DR⁺CD8⁺ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosis. [PDF]

Clin Transl Immunology
Fan J, Xu M, Liu K, Yan W, Wu H, Dong H, Yang Y, Ye W.   +7 more
europepmc   +1 more source